These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25984688)

  • 1. Systematic review on the efficacy, safety, and cost-effectiveness of topical calcineurin inhibitors in atopic dermatitis.
    Chia BK; Tey HL
    Dermatitis; 2015; 26(3):122-32. PubMed ID: 25984688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.
    Siegfried EC; Jaworski JC; Kaiser JD; Hebert AA
    BMC Pediatr; 2016 Jun; 16():75. PubMed ID: 27267134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.
    Frankel HC; Qureshi AA
    Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis.
    El-Batawy MM; Bosseila MA; Mashaly HM; Hafez VS
    J Dermatol Sci; 2009 May; 54(2):76-87. PubMed ID: 19303745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema.
    Pitt M; Garside R; Stein K
    Br J Dermatol; 2006 Jun; 154(6):1137-46. PubMed ID: 16704646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation.
    Garside R; Stein K; Castelnuovo E; Pitt M; Ashcroft D; Dimmock P; Payne L
    Health Technol Assess; 2005 Jul; 9(29):iii, xi-xiii,1-230. PubMed ID: 16022804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of Topical Corticosteroids and Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis.
    Pena J; Zameza PA; Pixley JN; Remitz A; Feldman SR
    J Allergy Clin Immunol Pract; 2023 May; 11(5):1347-1359. PubMed ID: 36997119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K; Werfel T; Kapp A
    Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
    Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical calcineurin inhibitors in the treatment of oral lichen planus: a systematic review and meta-analysis.
    Sun SL; Liu JJ; Zhong B; Wang JK; Jin X; Xu H; Yin FY; Liu TN; Chen QM; Zeng X
    Br J Dermatol; 2019 Dec; 181(6):1166-1176. PubMed ID: 30903622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A practical algorithm for topical treatment of atopic dermatitis in the Middle East emphasizing the importance of sensitive skin areas.
    Reda AM; Elgendi A; Ebraheem AI; Aldraibi MS; Qari MS; Abdulghani MMR; Luger T
    J Dermatolog Treat; 2019 Jun; 30(4):366-373. PubMed ID: 30222017
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas.
    Draelos ZD
    Curr Med Res Opin; 2008 Apr; 24(4):985-94. PubMed ID: 18284804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical treatment utilization for patients with atopic dermatitis in the United States, and budget impact analysis of crisaborole ointment, 2.
    Clark R; Bozkaya D; Levenberg M; Faulkner S; Smith TW; Gerber RA
    J Med Econ; 2018 Aug; 21(8):770-777. PubMed ID: 29706103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Position statement: topical calcineurin inhibitors in atopic dermatitis.
    Remitz A; De Pità O; Mota A; Serra-Baldrich E; Vakirlis E; Kapp A
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2074-2082. PubMed ID: 30288799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of topical medications in the management of paediatric atopic dermatitis: An updated systematic review.
    Zhao S; Hwang A; Miller C; Lio P
    Br J Clin Pharmacol; 2023 Jul; 89(7):2039-2065. PubMed ID: 37075252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
    Ashcroft DM; Dimmock P; Garside R; Stein K; Williams HC
    BMJ; 2005 Mar; 330(7490):516. PubMed ID: 15731121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence.
    Kalavala M; Dohil MA
    Am J Clin Dermatol; 2011 Feb; 12(1):15-24. PubMed ID: 21067248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spotlight on topical pimecrolimus in pediatric atopic dermatitis.
    Yang LP; Curran MP
    Am J Clin Dermatol; 2010; 11(4):295-8. PubMed ID: 20509720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Clinically Relevant Are Treatment Comparisons of Topical Calcineurin Inhibitor Trials for Atopic Eczema?
    Wilkes SR; Nankervis H; Tavernier E; Maruani A; Williams HC
    J Invest Dermatol; 2016 Oct; 136(10):1944-1949. PubMed ID: 27265005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence Review of Topical Calcineurin Inhibitors for the Treatment of Adult Atopic Dermatitis.
    Hong CH; Gooderham M; Bissonnette R
    J Cutan Med Surg; 2019; 23(4_suppl):5S-10S. PubMed ID: 31476937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.